DrugsControl Media Services
DrugsControl.org

News Detail

Tafenoquine single-dose medicine for P. vivax malaria prequalified by WHO and included in WHO Guidelines (05-12-2024)

London, United Kingdom and Geneva Switzerland,  4 Dec 2024: GSK plc and Medicines for Malaria Venture (MMV) announced today that the World Health Organization (WHO) has awarded prequalification to tafenoquine, the first single-dose medicine for the prevention of rel......
View Details

Source : Medicines for Malaria Venture
GSK plc Medicines for Malaria Venture (MMV) World Health Organization (WHO) tafenoquine single-dose medicine Plasmodium vivax (P. vivax) malaria

Related News